Oct 23, 2026 09:15AM
Oct 23, 2026 09:15AM
Oct 5, 2026 08:02AM
Oct 5, 2026 08:00AM
Oct 2, 2026 08:01AM
Oct 2, 2026 08:00AM
Sep 30, 2026 08:04AM Celcuity's Revtorpyk breast cancer drug now available in the US
Sep 30, 2026 08:00AM
Aug 26, 2026 08:32AM
Aug 26, 2026 08:30AM
Aug 17, 2026 07:12AM
Aug 17, 2026 04:16AM
Aug 13, 2026 04:06PM
Aug 6, 2026 08:34AM Celcuity Schedules Release of Second Quarter 2026 Financial Results and Webcast/Conference Call
Jul 30, 2026 08:30AM
Jul 30, 2026 08:30AM
Jul 15, 2026 07:36AM
Jul 15, 2026 07:23AM
Jul 15, 2026 07:22AM
Jul 14, 2026 04:53PM
Jul 14, 2026 04:53PM Celcuity Announces FDA Approval of REVTORPYK™ (gedatolisib) for the Treatment of HR+/HER2-, PIK3CA Wild-Type Locally Advanced or Metastatic Breast Cancer
Jun 3, 2026 10:13PM
Jun 3, 2026 10:13PM
Jun 3, 2026 07:19AM
Jun 3, 2026 07:19AM
Jun 2, 2026 08:26AM
Jun 2, 2026 08:25AM
Jun 2, 2026 08:11AM Celcuity reports positive Phase 3 trial results for gedatolisib in breast cancer
May 18, 2026 07:05AM
May 14, 2026 04:01PM
May 14, 2026 07:30AM
May 14, 2026 07:30AM
May 1, 2026 05:03PM
May 1, 2026 05:03PM
Mar 25, 2026 04:01PM Celcuity Inc. Reports Release of Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Mar 9, 2026 05:42PM
Mar 9, 2026 05:42PM
Feb 12, 2026 04:05PM
Feb 12, 2026 04:05PM
Jan 20, 2026 07:30AM
Jan 20, 2026 07:30AM
Jan 8, 2026 12:08PM The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech
Dec 11, 2025 02:35PM
Dec 11, 2025 02:35PM
Nov 17, 2025 04:05PM
Nov 12, 2025 04:01PM
Oct 18, 2025 04:30AM
Oct 18, 2025 04:30AM
Sep 9, 2025 04:01PM Celcuity increases term loan facility to $500 million
Sep 9, 2025 04:01PM

335,147 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All